CompaniesPinnacle Biologics

Pinnacle Biologics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

3

As Collaborator

5

Total Enrollment

1,037

By Phase

PHASE1/PHASE2: 1PHASE2: 2PHASE1: 2PHASE3: 1

By Status

WITHDRAWN: 3TERMINATED: 2COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT01842555
NCT01682746
NCT01770132
NCT01966809
NCT03735095
Hover over trial bars to see details

Recent Trials

NCT03735095Collaborator
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer
PHASE1/PHASE2Terminated
19 participants
Started: Feb 12, 2020 · Completed: Jul 26, 2024
NCT01966809Collaborator
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
PHASE2Terminated
1 participants
Started: Jun 30, 2015 · Completed: Dec 19, 2017
NCT01256203Lead Sponsor
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
PHASE2Withdrawn
Started: May 31, 2013 · Completed: Mar 31, 2014
NCT01770132Collaborator
Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
PHASE1Completed
12 participants
Started: Apr 19, 2013 · Completed: Oct 28, 2018
NCT01682746Collaborator
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
PHASE1Completed
5 participants
Started: Mar 31, 2013 · Completed: Jun 29, 2018
View all 8 trials →
Funding History (1)
D
Dec 29, 2011
Filing